JSPR
Price
$2.45
Change
-$0.03 (-1.21%)
Updated
Oct 17 closing price
Capitalization
68.41M
Intraday Buy/Sell Signals
TERN
Price
$8.41
Change
-$0.20 (-2.32%)
Updated
Oct 17 closing price
Capitalization
735.97M
31 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

JSPR vs TERN

Header iconJSPR vs TERN Comparison
Open Charts JSPR vs TERNBanner chart's image
Jasper Therapeutics
Price$2.45
Change-$0.03 (-1.21%)
Volume$218.99K
Capitalization68.41M
Terns Pharmaceuticals
Price$8.41
Change-$0.20 (-2.32%)
Volume$787.1K
Capitalization735.97M
JSPR vs TERN Comparison Chart in %
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JSPR vs. TERN commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSPR is a Hold and TERN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (JSPR: $2.45 vs. TERN: $8.41)
Brand notoriety: JSPR and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JSPR: 71% vs. TERN: 68%
Market capitalization -- JSPR: $68.41M vs. TERN: $735.97M
JSPR [@Biotechnology] is valued at $68.41M. TERN’s [@Biotechnology] market capitalization is $735.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JSPR’s FA Score shows that 2 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • JSPR’s FA Score: 2 green, 3 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, JSPR is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JSPR’s TA Score shows that 3 TA indicator(s) are bullish while TERN’s TA Score has 4 bullish TA indicator(s).

  • JSPR’s TA Score: 3 bullish, 5 bearish.
  • TERN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TERN is a better buy in the short-term than JSPR.

Price Growth

JSPR (@Biotechnology) experienced а +2.08% price change this week, while TERN (@Biotechnology) price change was +3.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

TERN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($736M) has a higher market cap than JSPR($68.4M). TERN YTD gains are higher at: 51.805 vs. JSPR (-88.541). JSPR has higher annual earnings (EBITDA): -92.73M vs. TERN (-105M). TERN has more cash in the bank: 315M vs. JSPR (39.5M). TERN has less debt than JSPR: TERN (1.13M) vs JSPR (2.16M). JSPR (0) and TERN (0) have equivalent revenues.
JSPRTERNJSPR / TERN
Capitalization68.4M736M9%
EBITDA-92.73M-105M88%
Gain YTD-88.54151.805-171%
P/E RatioN/AN/A-
Revenue00-
Total Cash39.5M315M13%
Total Debt2.16M1.13M190%
TECHNICAL ANALYSIS
Technical Analysis
JSPRTERN
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGRX60.280.29
+0.48%
MFS Core Equity I
GSTTX15.520.07
+0.45%
Goldman Sachs Strategic Growth Inv
IRMTX10.230.03
+0.29%
Voya Russell Mid Cap Index Port S2
TEMRX10.090.02
+0.20%
Nuveen Emerging Markets Eq A
PGEIX9.94-0.03
-0.30%
Polen Emerging Markets Growth Inst

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-1.21%
AUPH - JSPR
44%
Loosely correlated
N/A
ETHZ - JSPR
38%
Loosely correlated
+0.60%
DSGN - JSPR
35%
Loosely correlated
-6.97%
AVXL - JSPR
35%
Loosely correlated
-0.33%
TERN - JSPR
35%
Loosely correlated
-2.32%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-2.32%
SYRE - TERN
53%
Loosely correlated
+1.03%
BEAM - TERN
52%
Loosely correlated
+0.74%
IDYA - TERN
51%
Loosely correlated
+5.67%
VRDN - TERN
49%
Loosely correlated
+5.22%
XNCR - TERN
48%
Loosely correlated
-1.20%
More